NGF and early-onset autosomal dominant Alzheimer disease: Nerve Growth Factor (NGF) [1] has a considerable therapeutic potential for Alzheimer's disease (AD), not merely as a long-lasting cholinergic maintenance [2], [3], [4] and neuroprotective agent [5], [6], but also as a direct anti-amyloidogenic factor [7], [8].